DPP4 and metabolic dysfunction-associated steatotic liver disease: Dipeptidyl peptidase-4 (DPP-4) is an important target for the clinical treatment of several diseases including diabetes, obesity, cardiovascular diseases, and non-alcoholic fatty liver disease (NAFLD) [1,2,3,4,5,6].